Aberrant expression of the esophageal carcinoma related gene 4 as a prognostic signature for hepatocellular carcinoma

Yu, 2008, Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors, Hepatology, 48, 508, 10.1002/hep.22343 Siegel, 2015, Cancer statistics, CA Cancer J Clin, 65, 5, 10.3322/caac.21254 You, 2015, ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma, Cell Oncol, 38, 205, 10.1007/s13402-015-0223-y Qin, 2018, ECRG4: a new potential target in precision medicine, Front Med, 13, 540, 10.1007/s11684-018-0637-9 Su, 1998, Cloning and identification of cDNA fragments related to human esophageal cancer, Chin J Oncol (Zhonghua Zhong Liu Za Zhi), 20, 254 Rasool, 2013, ECRG1 and its relationship with esophageal cancer: a brief review, Onkologie, 36, 213 Zhao, 2004, Induction of G1 cell cycle arrest and P15INK4b expression by ECRG1 through interaction with Miz-1, J Cell Biochem, 92, 65, 10.1002/jcb.20025 Hou, 2017, ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells upregulation of and downregulation of PCNA, World J Gastroenterol, 23, 1796, 10.3748/wjg.v23.i10.1796 Cheng, 2009, ECRG2 regulates cell migration/invasion through urokinase-type plasmin activator receptor (uPAR)/beta1 integrin pathway, J Biol Chem, 284, 30897, 10.1074/jbc.M109.011213 Huang, 2007, ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity, Carcinogenesis, 28, 2274, 10.1093/carcin/bgm140 Jiang, 2013, Overexpression of ECRG4 enhances chemosensitivity to 5-fluorouracil in the human gastric cancer SGC-7901 cell line, Tumour Biol, 34, 2269, 10.1007/s13277-013-0768-1 Yueying, 2008, Shih-Hsin L. ECRG1, a novel esophageal gene, cloned and identified from human esophagus and its inhibition effect on tumors, Carcinogenesis, 29, 157, 10.1093/carcin/bgm203 Li, 2011, A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma, BMC Cancer, 11 Luo, 2016, Downregulated ECRG4 is associated with poor prognosis in renal cell cancer and is regulated by promoter DNA methylation, Tumour Biol, 37, 1121, 10.1007/s13277-015-3913-1 Sabatier, 2011, Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer, PLoS ONE, 6, e27656, 10.1371/journal.pone.0027656 Götze, 2009, ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma, BMC Cancer, 9, 447, 10.1186/1471-2407-9-447 Deng, 2018, Downregulation and DNA methylation of ECRG4 in gastric cancer, Onco Targets Ther, 11, 4019, 10.2147/OTT.S161200 Wen, 2015, Expression of esophageal carcinoma related gene 4 (ECRG4) and its clinical significance in prognosis of esophageal carcinoma, Int J Clin Exp Pathol, 8, 14772 You, 2016, Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis-A short report, Cell Oncol, 39, 89, 10.1007/s13402-015-0260-6 Rhodes, 2004, ONCOMINE: a cancer microarray database and integrated data-mining platform, Neoplasia, 6, 1, 10.1016/S1476-5586(04)80047-2 Liu, 2018, GSCALite: a Web Server for Gene Set Cancer Analysis, Bioinformatics, 34, 3771, 10.1093/bioinformatics/bty411 Barretina, 2012, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancerdrug sensitivity, Nature, 483, 603, 10.1038/nature11003 Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, 11, 10.1126/scisignal.2004088 Nagy, 2021, Pancancer survival analysis of cancer hallmark genes, Sci Rep, 11, 6047, 10.1038/s41598-021-84787-5 Menyhart, 2018, Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma, R Soc Open Sci, 5, 10.1098/rsos.181006 Blessmann, 2009, Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients, Int J Oral Maxillofac Surg, 38, 779, 10.1016/j.ijom.2009.02.021 Bachmann, 2009, Polymorphism Arg290Arg in esophageal-cancer-related gene 1 (ECRG1) is a prognostic factor for survival in esophageal cancer, J Gastrointest Surg, 13, 181, 10.1007/s11605-008-0766-6 Li, 2006, Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma, Carcinogenesis, 27, 798, 10.1093/carcin/bgi258 Zhao, 2004, Induction of G1 cell cycle arrest and P15INK4b expression by ECRG1 through interaction with Miz-1, J Cell Biochem, 92, 65, 10.1002/jcb.20025 Li, 2011, A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma, BMC Cancer, 11, 52, 10.1186/1471-2407-11-52 Wang, 2006, ECRG1, a novel esophageal gene, cloned and identified from human esophagus and its inhibition effect on tumors, Carcinogenesis, 27, 798 Blessmann, 2008, Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma, Oral Oncol, 44, 143, 10.1016/j.oraloncology.2007.01.013 Kaifi, 2007, Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer, Am J Surg, 194, 380, 10.1016/j.amjsurg.2007.01.026 Huang, 2007, ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity, Carcinogenesis, 28, 2274, 10.1093/carcin/bgm140 Cheng, 2009, ECRG2 regulates cell migration/invasion through urokinase-type plasmin activator receptor (uPAR)/beta1 integrin pathway, J Biol Chem, 284, 30897, 10.1074/jbc.M109.011213 Cheng, 2010, ECRG2 regulates ECM degradation and uPAR/FPRL1 pathway contributing cell invasion/migration, Cancer Lett, 290, 87, 10.1016/j.canlet.2009.09.001 Vanaja, 2009, Hypermethylation of genes for diagnosis and risk stratification of prostate cancer, Cancer Invest, 27, 549, 10.1080/07357900802620794 Chen, 2017, Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients, Clin Transl Oncol, 19, 84, 10.1007/s12094-016-1507-z